xana Sampaio – Medialis

Linkedin Made by Medialis Patient Payor Prescriber Regulator Uncategorized

The association between influenza vaccine effectiveness and egg-based manufacturing technology: literature review and US expert consensus

November 21, 20240

Reference: Chatterjee A, Ambrose K, Canaday DH, Delair S, Ezike N, Huber VC, Jhaveri R, Nyquist AC, Sporer A, Varman M, Vivekanandan R. The association between influenza vaccine effectiveness and egg-based manufacturing technology: literature review and US expert consensus. Current medical research and opinion. 2024 Feb 1;40(2):335-43. Background Influenza is associated with significant disease burden...

Linkedin Made by Medialis Patient Payor Prescriber Regulator Uncategorized

Real-world service costs for neovascular-AMD clinics in the United Kingdom: structured literature review and scenario analysis

November 21, 20240

Reference: Sivaprasad S, Bailey C, Downey L, Gilbert R, Gale R, Kotagiri A, Mahmood S, Morgan-Warren P, Napier J, Narendran N, Pearce I. . Real-world service costs for neovascular-AMD clinics in the United Kingdom: structured literature review and scenario analysis. Current Medical Research and Opinion. 2024 Jul 2;40(7):1221-33. Objective Current cost-effectiveness analyses (CEA) emphasize drug...

Linkedin Made by Medialis Patient Payor Prescriber Regulator Uncategorized

A simple core dataset for triglyceride-induced acute pancreatitis

November 19, 20240

Reference: Freedman S, De-Madaria E, Singh VK, Bruckert E, Löhr M, Sutton R, Rebours V, Jones R, Jandhyala R. A simple core dataset for triglyceride-induced acute pancreatitis. Current Medical Research and Opinion. 2023 Jan 2;39(1):37-46. Objective The objective of this study is to generate a core clinical dataset (CD) containing the minimum acceptable amount of...

Linkedin Made by Medialis Patient Payor Prescriber Regulator Uncategorized

Observing expert opinion of medical affairs pharmaceutical physicians on the value of their clinical experience to the pharmaceutical industry using the Jandhyala method

November 19, 20240

Reference: Jandhyala R, Rout R. Observing expert opinion of medical affairs pharmaceutical physicians on the value of their clinical experience to the pharmaceutical industry using the Jandhyala method. Current Medical Research and Opinion. 2023 Dec 2;39(12):1541-50. Background The pharmaceutical industry requires a highly qualified workforce with diverse skillsets. Medical affairs pharmaceutical physicians (MAPPs) have unique...

Linkedin Made by Medialis Patient Payor Prescriber Regulator

Development of a definition for real-world evidence using the Jandhyala method for observing consensus opinion among medical affairs pharmaceutical physicians

November 19, 20240

Reference: Jandhyala R. Development of a definition for real-world evidence using the Jandhyala method for observing consensus opinion among medical affairs pharmaceutical physicians. Current Medical Research and Opinion. 2023 Dec 2;39(12):1551-8. Objective Low rates of inclusion of real-world evidence (RWE) during regulation may arise from lack of clarity and consensus on its definition. A conceptually...

Hypertriglyceridemia research priorities

Linkedin Made by Medialis Patient Payor Prescriber Regulator

Observed consensus on research priorities for the hypertriglyceridemia patient registry

November 19, 20240

Reference: Freedman S, de-Madaria E, Bruckert E, Löhr M, Rebours V, Jandhyala R. Observed consensus on research priorities for the hypertriglyceridemia patient registry. Current Medical Research and Opinion. 2023 Dec 2;39(12):1629-35. Background Priority setting in health research has been described as essential due to disparities within and between countries and populations. Commercial benefits to the...

Linkedin Made by Medialis Patient Payor Prescriber Regulator

Commercial impact of adding real-world evidence to clinical trials at regulatory approval: a Markovian-like transition model

November 19, 20240

Reference: Jandhyala R. Commercial impact of adding real-world evidence to clinical trials at regulatory approval: a Markovian-like transition model. Current Medical Research and Opinion. 2023 Dec 2;39(12):1559-66. Objective Regulatory use of real-world evidence (RWE) has been recognized as a useful supplement to clinical trial evidence and could benefit patients by reducing time to treatment. However,...

Linkedin Made by Medialis Patient Payor Prescriber Regulator

Development, validation and implementation of the medical affairs pharmaceutical physician work-related quality of life instrument

November 19, 20240

Reference: Jandhyala R.Development, validation and implementation of the medical affairs pharmaceutical physician work-related quality of life instrument. Current Medical Research and Opinion. 2023 Dec 2;39(12):1567-74. Background Medical affairs pharmaceutical physicians (MAPPs) are at risk for low work-related quality of life (WRQoL). The aim of this study was to develop, validate and implement the first WRQoL...

Linkedin Made by Medialis Patient Payor Prescriber Regulator

A protocol for an international, multicenter, prospective, non-interventional observational registry for patients with hypertriglyceridemia

November 19, 20240

Reference: Freedman S, de-Madaria E, Bruckert E, Löhr M, Rebours V, Jandhyala R. A protocol for an international, multicenter, prospective, non-interventional observational registry for patients with hypertriglyceridemia. Current Medical Research and Opinion. 2023 Dec 2;39(12):1663-70. Background In the study on triglyceride-induced pancreatitis (TG-IAP), a core clinical dataset using the Jandhyala method was developed to collect...

Linkedin Made by Medialis Patient Payor Prescriber Regulator

Adaptation and validation of the PAC-19QoL-specific quality of life questionnaire for the Spanish population with long COVID

November 19, 20240

Reference: Marcilla-Toribio I, Martinez-Andres M, Moratalla-Cebrian ML, Jandhyala R, Femi-Ajao O, Galan-Moya EM. Adaptation and validation of the PAC-19QoL-specific quality of life questionnaire for the Spanish population with long COVID. Current Medical Research and Opinion. 2023 Dec 2;39(12):1685-93. Introduction The post-acute (long) COVID-19 Quality of Life instrument is the only specific instrument designed to assess...

Older Posts